Gliptin-induced bullous pemphigoid: withdrawal of gliptin allows for faster control of the disease

Prugnit-Rouanet, Méryll; Delaumenie, Stéphanie; Couraud, Amélie; Audevard, Damien; Rouanet, Jacques; Bedane, Christophe

Prugnit-Rouanet, Méryll; Delaumenie, Stéphanie; Couraud, Amélie; Audevard, Damien; Rouanet, Jacques; Bedane, Christophe.

Afiliação

Prugnit-Rouanet M; Department of dermatology CHU Limoges, National Reference Center for Bullous Diseases, Limoges, France
Delaumenie S; Deparment of Dermatology CH Brive, France
Couraud A; Department of dermatology CHU Limoges, National Reference Center for Bullous Diseases, Limoges, France
Audevard D; Department of dermatology CHU Limoges, National Reference Center for Bullous Diseases, Limoges, France
Rouanet J; Department of Dermatology and Oncodermatology, University Hospital, Université Clermont Auvergne, Clermont-Ferrand, France
Bedane C; Department of dermatology CHU Limoges, National Reference Center for Bullous Diseases, Limoges, France

Eur J Dermatol ; 32(3): 368-372, 2022 05 01.

Article em En | MEDLINE | ID: mdl-36065541

Assuntos

Inibidores da Dipeptidil Peptidase IV; Penfigoide Bolhoso; Inibidores da Dipeptidil Peptidase IV/efeitos adversos; Humanos; Penfigoide Bolhoso/induzido quimicamente; Penfigoide Bolhoso/tratamento farmacológico; Estudos Retrospectivos; Vildagliptina/efeitos adversos

Palavras-chave

bullous pemphigoid; gliptin; treatment period; complete response

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Penfigoide Bolhoso / Inibidores da Dipeptidil Peptidase IV Tipo de estudo: Guideline / Observational_studies Limite: Humans Idioma: En Revista: Eur J Dermatol Assunto da revista: DERMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google